ASIA BEAT: More to come as China-Taiwan build pharma bridges
This article was originally published in Scrip
Executive Summary
While the pullback in China's stock market has been grabbing all the media attention, important new signs of the Asian giant's improving relations with Taiwan with clear implications for the healthcare/pharma sector have slipped under the radar mostly unnoticed.